Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms
Open accessAbstract
Saponins are triterpenoid or steroidal glycosides and are an important group of naturally occurring compounds of plant origin. They exhibit diverse pharmacological potentials including radical scavenging, as well as neuroprotective, anti-diabetic and anti-inflammatory activities, owing to their diverse chemical scaffolds. Saponins consist of an aglycone part (non-sugar) and a glycone part (sugar) and have at least one glycosidic (C–O sugar bond) linkage present between the glycone and aglycone mostly at C-3. On the basis of the aglycone part, saponins are classified into triterpenoid glycosides, steroid glycosides and alkaloid glycosides. Saponins exhibit neuroprotective activities against various disorders of the central nervous system (CNS) including stroke, Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD). They mediate their therapeutic effects by modulation of various pathological targets. This study highlights various neuroprotective mechanisms of saponins including free radical scavenging, modulation of neuroprotective signaling pathways, activation of neurotrophic factors, modulation of neurotransmitters, inhibition of BACE1 enzyme and tau hyper-phosphorylation. The study concludes that saponins have considerable efficacy against various pathological targets of neurological disorders, especially AD, and might be an important source of leads against neurodegenerative disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The blood-brain barrier (BBB) is an important impediment to the development of AD medications because it prevents potential drug candidates from entering the brain parenchyma.
“An important impediment to the development of AD medications is the blood–brain barrier (BBB), which prevents potential drug candidates from entering the brain parenchyma.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [194]
The indicated BBB penetration values are inconsistent with the physicochemical characteristics of monoclonal antibodies (solanezumab, aducanumab, bapineuzumab) or gamma-secretase inhibitors (semagacestat, tarenflurbil).
“The indicated BBB penetration values are inconsistent with the physicochemical characteristics of monoclonal antibodies (solanezumab, aducanumab, bapineuzumab) or gamma-secretase inhibitors (semagacestat, tarenflurbil) [193,194,195].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [194]
Candidates for BBB penetration are characterized by molecular weight less than 450 Daltons, polar surface area less than 90 Å2, and hydrogen bond donor number less than 3.
“A molecular weight less than 450 Daltons, a polar surface area less than 90 Å2, and a hydrogen bond donor number less than 3 are characteristics of candidates for BBB penetration.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [194]
For a medicine to penetrate the BBB, its physicochemical properties-polar surface area, molecular weight, and lipophilicity as assessed by hydrogen bonding ability-are essential.
“For a medicine to penetrate the blood–brain barrier, its physicochemical properties—such as its polar surface area, molecular weight, and lipophilicity as assessed by hydrogen bonding ability—are essential.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [194]
The BBB is impermeable to 98% of small molecules and around 100% of large molecules in relevant quantities.
“The BBB is impermeable to 98% of small molecules and around 100% of large molecules in relevant quantities.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Karthika, C., Appu, A. P., Akter, R., Rahman, M. H., Tagde, P., Ashraf, G. M., Abdel‐Daim, M. M., Hassan, S. S. U., Abid, A., & BUNGAU, S. G. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17830-7 · Cited by 45 · cited 2× · see citing works
“According to one mid-range estimate, the annual per-patient cost is $38,000, excluding the losses due to unemployment, premature deaths and morbidity [8].”
BackgroundSelf-citationRetractedInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642 · cited 1× · see citing works
“The global prevalence of AD is estimated to be 35 million [12].”
BackgroundSynapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · see citing works
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353 · see citing works
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works
Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · cited 1× · see citing works
“Another cause of AD pathogenesis is the cholinergic neuronal loss, which leads to a gradual decline in the number of cholinergic neurons [33].”
BackgroundBrookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471 · see citing works
Biological activities and distribution of plant saponins
Sparg, S. G., Light, M. E., & van Staden, J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.05.016 · Cited by 1,469 · cited 1× · see citing works
“Various plant families synthesize and store saponins [78,80,81].”
BackgroundEpidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261 · cited 2× · see citing works
“1% were tested for their efficacy in modulating the neuropsychiatric symptoms [9].”
BackgroundSaponins: Properties, Applications and Processing
Üstündağ, Ö. G., & Mazza, G. A. (2007) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390600698197 · Cited by 1,048 · cited 1× · see citing works
“Saponin-rich plants are used for various purposes and are considered as the main ingredients in Traditional Chinese Medicine (TCM); these plants notably include ginseng [72].”
BackgroundSaponins, classification and occurrence in the plant kingdom
Vincken, J., Heng, L., de Groot, C. P. G. M., & Gruppen, H. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.10.008 · Cited by 798 · cited 5× · see citing works
“Likewise, the anti-hyperphosphorylation and anti-neuroinflammatory effects of theasaponin E1 isolated from green tea was studied using neuroblastoma (SHY-5Y) and glioblastoma (HTB2) cells [77].”
BackgroundMethodInfluentialOno, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681 · see citing works
Memory loss in Alzheimer's disease
Jahn, H. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/hjahn · Cited by 653 · cited 1× · see citing works
“Alzheimer’s disease (AD) is a highly prevalent neurological disorder of old age and associated with behavioral and cognitive complications [1,2].”
BackgroundThe discovery of Alzheimer's disease
Hippius, H., & Neundörfer, G. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/hhippius · Cited by 516 · cited 1× · see citing works
“As the AD progresses, atrophy occurs in the area of the cortex, which controls sensory processing, reasoning, conscious thoughts and speech, and the symptoms of AD such as long term memory impairment, weight loss, seizures, unable to recognize loved ones, and incontinence become severe [19,20].”
BackgroundSaponins from Edible Legumes: Chemistry, Processing, and Health Benefits
Shi, J., Arunasalam, K., Yeung, D., Kakuda, Y., Mittal, G., & Jiang, Y. (2004) · Journal of Medicinal Food · doi:10.1089/109662004322984734 · Cited by 479 · see citing works
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Tam, K. Y., & Ju, Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320970 · Cited by 416 · cited 2× · see citing works
“The symptoms of AD are not confined to the loss of memory and cognition, but it also associated with some noncognitive characteristics such as depression, inability to perform routine daily activities and behavioral disturbances [3,4].”
BackgroundEstimated Prevalence of Alzheimer's Disease in the United States
Evans, D. A. (1990) · Milbank Quarterly · doi:10.2307/3350099 · Cited by 356 · cited 1× · see citing works
“A study aimed to evaluate the actual and estimated prevalence of AD–dementia in US from 2010–2050 using longitudinal population-based analysis [13].”
MethodProtective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease
Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., Kuruva, C. S., Bhatti, J. S., Kandimalla, R., Vijayan, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170512 · Cited by 354 · see citing works
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Ovais, M., Ullah, I., Ahmed, J., & Shahid, M. M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00155 · Cited by 348 · cited 1× · see citing works
“Normally, the products of β-secretase (BACE1) are subsequently metabolized by γ-secretase, thus resulting in the formation of soluble peptides composed of 40 amino acids [27].”
BackgroundSelf-citationAnti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action
CHENG, Y., Shen, L., & Zhang, J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00034.x · Cited by 338 · cited 1× · see citing works
“Furthermore, the effect produced by ginsenoside K on the axonal reconstruction was verified in the cultured cortical neurons [93].”
BackgroundNeuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Subhan, F., & Ahmed, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00168 · Cited by 287 · cited 1× · see citing works
“The Aβ plaques are insoluble peptides which are formed from the abnormal segmentation of APP (amyloid precursor proteins) [26] (Figure 1).”
BackgroundSelf-citationInflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Zotova, E., Nicoll, J. A. R., Kalaria, R. N., Holmes, C., & Boche, D. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt24 · Cited by 257 · cited 1× · see citing works
“However, it is unlikely that inflammation is the sole cause of AD, but it is definitely implicated in the progression of the disease [42].”
BackgroundA review on saponins from medicinal plants: chemistry, isolation, and determination
Ashour, A. S., Aziz, M. M. A. E., & Melad, A. G. (2019) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2019.07.00199 · Cited by 245 · cited 2× · see citing works
“Various plant families synthesize and store saponins [78,80,81].”
BackgroundOsbourn, A. (2002) · Phytochemistry · doi:10.1016/s0031-9422(02)00393-x · Cited by 213 · see citing works
First encounters – deployment of defence‐related natural products by plants
Field, B., Jordán, F., & Osbourn, A. (2006) · New Phytologist · doi:10.1111/j.1469-8137.2006.01863.x · Cited by 197 · cited 1× · see citing works
“Some members of the family Solanaceae such as potato, tomato, capsicum and aubergine have glycoalkaloids [89,90].”
BackgroundNeurofibrillary Tangles and Alzheimer’s Disease
Brion, J. (1998) · European Neurology · doi:10.1159/000007969 · Cited by 194 · cited 1× · see citing works
“The thread of a neuropil consists of small-sized curly and dystrophic neurites that are scattered in neuropils and holding some abnormal filaments [31,32].”
BackgroundButterfield, D. A., Griffin, S. T., Münch, G. W., & Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4309 · Cited by 174 · see citing works
Horsburgh, K. J., McCarron, M. O., White, F., & Nicoll, J. A. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00097-x · Cited by 169 · cited 1× · see citing works
“For instance, the presence of polymorphic genes encoding IL-1 and TNFα were reported to cause excessive activation of microglia among AD patients [49,50].”
BackgroundAmyloid-β-Induced Mitochondrial Dysfunction
Chen, J. X., & Yan, S. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12208 · Cited by 167 · cited 1× · see citing works
“The Aβ plaques are considered to be responsible for the pathogenesis of AD (amyloid hypothesis) [22,23].”
BackgroundGinsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress
Chen, X. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01945-9 · Cited by 166 · see citing works
Microglial Activation in Alzheimer Disease: Association with APOE Genotype
Egensperger, R., Kösel, S., von Eitzen, U., & Graeber, M. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00166.x · Cited by 164 · cited 1× · see citing works
“Though the role of APOE gene polymorphisms, especially in APOEe4 carriers, is suggested to be involved, its exact mechanism remains unclear [51,52].”
BackgroundReductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides
Chen, F., Eckman, E. A., & Eckman, C. B. (2006) · The FASEB Journal · doi:10.1096/fj.05-5530fje · Cited by 160 · cited 1× · see citing works
“This provides valuable data to treat AD and some other neurodegenerative disorders that involve the loss of neurons [94].”
BackgroundNaturally Occurring Triterpenoid Saponins
Dinda, B., Debnath, S., Mohanta, B. C., & Harigaya, Y. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200800070 · Cited by 158 · cited 1× · see citing works
“Similarly, when the alkaloid aglycone is combined with a sugar moiety, it forms an alkaloid saponin [79].”
BackgroundZhang, G., Liu, A., Zhou, Y., San, X., Jin, T., & Jin, Y. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.026 · Cited by 157 · see citing works
Liu, J., & Henkel, T. O. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369709 · Cited by 157 · cited 1× · see citing works
“Saponins represent a group of naturally occurring organic compounds distributed in the kingdom plantae [71].”
BackgroundAccumulation of tau induced in neurites by microglial proinflammatory mediators
Gorlovoy, P., Larionov, S., Pham, T. T. H., & Neumann, H. (2009) · The FASEB Journal · doi:10.1096/fj.08-123877 · Cited by 156 · cited 1× · see citing works
“Additionally, the activated microglia cause phosphorylation of tau proteins, which subsequently leads to the formation and neuronal accumulation of NFTs [46,47].”
BackgroundOxidative Imbalance in Alzheimer's Disease
Zhu, X., Lee, H., Casadesús, G., Ávila, J., Drew, K. L., Perry, G. L., & Smith, M. A. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:205 · Cited by 146 · cited 1× · see citing works
“This oxidation process in neurons causes various problems including non-recoverable DNA damage and upregulation of pro-inflammatory cytokines [37,38].”
BackgroundAnti-inflammatory mechanism of ginseng saponins in activated microglia
Park, J., Park, E., Kim, D., Jung, K., Jung, J.-S., Lee, E.-J., Hyun, J., Kang, J. L., & Kim, H.-S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.020 · Cited by 143 · cited 1× · see citing works
“ginseng Ginsenoside Rg2 Stroke Anti-apoptosis [115,116]”
Tohda, C., Matsumoto, N., Zou, K., Meselhy, M. R., & Komatsu, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300388 · Cited by 139 · see citing works
Vauzour, D. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6473 · Cited by 136 · see citing works
Sun, A., Xu, X., Lin, J., Cui, X., & Xu, R. (2014) · Phytotherapy Research · doi:10.1002/ptr.5246 · Cited by 135 · see citing works
Microglia and Alzheimer’s disease
Kalaria, R. N. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199901000-00004 · Cited by 132 · cited 1× · see citing works
“Subsequently, potentially neurotoxic chemicals such as cytokines, chemokines, reactive nitrogen species (RNS), reactive oxygen species (ROS), as well as proteolytic enzymes, are liberated, which initiate neuronal degeneration [44,45].”
BackgroundAyaz, M., Junaid, M., Ullah, F., Sadiq, A., Khan, M. A., Ahmad, W., Shah, M. R., Imran, M., & Ahmad, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0145-8 · Cited by 128 · cited 1× · see citing works
“In addition to loss of memory, norepinephrine has been considered to be responsible for the psychological and behavioral symptoms of dementia (psychosis, agitation and aggression) [54].”
BackgroundSelf-citationYe, R., Li, N., Han, J., Kong, X., Cao, R. Y., Rao, Z., & Zhao, G. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.03.016 · Cited by 124 · cited 1× · see citing works
“Ginsenoside Rd reduces H2O2-mediated oxidative stress using PC12 cells [113].”
MethodOvais, M., Zia, N., Ahmad, I., Khalil, A., Raza, A., Ayaz, M., Sadiq, A., Ullah, F., & Shinwari, Z. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00284 · Cited by 120 · cited 1× · see citing works
“The Aβ plaques are considered to be responsible for the pathogenesis of AD (amyloid hypothesis) [22,23].”
BackgroundSelf-citationThe Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
Herrmann, N., Lanctôt, K. L., & Khan, L. R. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.261 · Cited by 118 · cited 1× · see citing works
“The level of norepinephrine is also decreased and its neurons are lost in AD [53].”
BackgroundLee, B., Jung, K., & Kim, D. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.021 · Cited by 111 · cited 1× · see citing works
“2 Liriope platyphylla Spicatoside A AD Nerve growth factor (NGF), extracellular signal-regulated kinase (ERK), PI3-kinase/serine/threonine kinase (AKT), Cell surface transmembrane receptor tyrosine kinase (TrkA) receptor activation, neural networks reconstruction [105]”
BackgroundIt May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease
Arnaud, L. T., Robakis, N. K. R. K., & Figueiredo‐Pereira, M. E. (2006) · Neurodegenerative Diseases · doi:10.1159/000095638 · Cited by 102 · cited 1× · see citing works
“Subsequently, potentially neurotoxic chemicals such as cytokines, chemokines, reactive nitrogen species (RNS), reactive oxygen species (ROS), as well as proteolytic enzymes, are liberated, which initiate neuronal degeneration [44,45].”
BackgroundInsights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease
Wang, X., Su, B., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.007 · Cited by 102 · cited 2× · see citing works
“Aβ is known as mitochondrial poison, which, after fabrication, localizes to mitochondrial membranes and blocks the nuclearencoded mitochondrial protein transport to mitochondria [24].”
BackgroundEconomic research on Alzheimer disease: a review of the literature.
Ernst, R. L., & Hay, J. W. (1997) · PubMed · Cited by 102 · see citing works
Role of medicinal plants in neurodegenerative diseases
Ratheesh, G., Tian, L., Venugopal, J. R., Ezhilarasu, H., Sadiq, A., Fan, T.-P., & Ramakrishna, S. (2017) · Biomanufacturing Reviews · doi:10.1007/s40898-017-0004-7 · Cited by 99 · see citing works
Choi, S., Kim, B. C., Cho, Y.-H., Choi, K., Chang, J. Y., Park, M., Kim, M., Cho, K.-H., & Kim, J.-K. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.45 · Cited by 98 · see citing works
Carter, J. P., Spink, J., Cannon, P. F., Daniels, M. J., & Osbourn, A. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.8.3364-3372.1999 · Cited by 97 · cited 1× · see citing works
“Some members of the family Solanaceae such as potato, tomato, capsicum and aubergine have glycoalkaloids [89,90].”
BackgroundNeuroprotective effect of individual ginsenosides on astrocytes primary culture
López, M. V. N., Gómez-Serranillos, M. P., Palomino, O. M., Fresno, Á. M. V. D., & Accame, M. E. C. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.06.008 · Cited by 96 · see citing works
Mattila, P., Rinne, J., Helenius, H., & Röyttä, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051064 · Cited by 95 · see citing works
Ayaz, M., Junaid, M., Ullah, F., Sadiq, A., Subhan, F., Khan, M. A., Ahmad, W., Ali, G., Imran, M., & Ahmad, S. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00074 · Cited by 93 · see citing works
Self-citationGinsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells
Cao, G., Su, P., Zhang, S., Guo, L., Zhang, H., Liang, Y., Qin, C., & Zhang, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.006 · Cited by 91 · see citing works
Ayaz, M., Ullah, F., Sadiq, A., Kim, M. O., & Ali, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01417 · Cited by 90 · see citing works
Self-citationThe cortical neuritic pathology of Huntington's disease
Jackson, M., Gentleman, S. M., Lennox, G. G., Ward, L., Gray, T. B., Randall, K., Morrell, K., & Lowe, J. S. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01024.x · Cited by 89 · see citing works
Xu, C.-L., Wang, Q.-Z., Sun, L.-M., Li, X.-M., Deng, J.-M., Li, L.-F., Zhang, J., Xu, R., & Ma, S.-P. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.014 · Cited by 85 · cited 1× · see citing works
“ginseng Ginsenoside Rc HD Ca2+ signaling pathway [124]”
BackgroundWu, J., Jeong, H. K., Bulin, S. E., Kwon, S. W., Park, J. H., & Борисович, Б. И. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22017 · Cited by 85 · cited 1× · see citing works
“ginseng Ginsenoside Rb3 Neurite growth Antioxidant, GABA receptor, neurite outgrowth enhancing [123]”
BackgroundXu, C.-L., Qu, R., Zhang, J., Li, L.-F., & Ma, S.-P. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.07.009 · Cited by 84 · cited 1× · see citing works
“Hence it attenuates the MPTP-elevated levels of iron, reduces the expression of DMT1 and increases the expression of FP1 in the SN [102].”
BackgroundTwo decades of new drug discovery and development for Alzheimer's disease
Liu, Z., Zhang, A., Sun, H. J., Han, Y., Kong, L. D., & Wang, X. (2017) · RSC Advances · doi:10.1039/c6ra26737h · Cited by 83 · cited 1× · see citing works
“The symptoms of AD are not confined to the loss of memory and cognition, but it also associated with some noncognitive characteristics such as depression, inability to perform routine daily activities and behavioral disturbances [3,4].”
BackgroundGravel, M., Polo, A. D., Valera, P. B., & Braun, P. E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980815)53:4 · Cited by 82 · see citing works
Mir, N. T., Saleem, U., Anwar, F., Ahmad, B., Ullah, I., Hira, S., Ismail, T., Ali, T., & Ayaz, M. (2019) · Medicina · doi:10.3390/medicina55050192 · Cited by 82 · cited 1× · see citing works
“These neurotransmitters have a significant role in mood and memory, and include serotonin, acetylcholine, norepinephrine and glutamate; all of these are implicated in the pathology of AD [34].”
BackgroundSelf-citationOmura, J. D., McGuire, L. C., Patel, R., Baumgart, M., Lamb, R., Jeffers, E. M., Olivari, B. S., Croft, J. B., Thomas, C. W., & Hacker, K. A. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7120a2 · Cited by 82 · cited 1× · see citing works
“The prevalence of AD is found to be higher among women as compared to men [17].”
BackgroundLuo, F., Wang, S., Qi, L., Song, J., Lv, T., & Bai, J. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.10.017 · Cited by 81 · cited 2× · see citing works
“9 Dipsacus asper Akebia saponin D AD mitogen-activated protein kinase (MAPK) anti- apoptosis [99]”
BackgroundHe, X., Zhu, Y., Yang, L., Wang, Z., Wang, Z., Feng, J., Wen, X., Cheng, L., & Zhu, R. (2021) · Advanced Science · doi:10.1002/advs.202003535 · Cited by 81 · cited 1× · see citing works
“The tubers of Dioscorea villosa (wild yam) have saponin dioscin in abundance, which upon hydrolysis, gives diosgenin, a steroidal aglycone, which is used as a precursor for steroid synthesis, including pregnenolone, progesterone and cortisone commercially [87,88].”
BackgroundWang, J., Xu, H., Yang, H., Du, X., Jiang, H. F., & Xie, J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.003 · Cited by 79 · cited 1× · see citing works
“Ginsenoside Re helps in the dopaminergic neuron protection from MPTP-induced apoptosis via the expression of Bcl mRNA, elevating Bcl-2 protein (an apoptotic protein) levels, lowering the Bax protein (a pro-apoptotic protein) levels, the expression of Bax mRNA and inhibiting the activation of caspase-3 in the PD mouse…”
BackgroundZhu, X., Raina, A. K., & Smith, M. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65127-9 · Cited by 77 · cited 1× · see citing works
“This oxidation process in neurons causes various problems including non-recoverable DNA damage and upregulation of pro-inflammatory cytokines [37,38].”
BackgroundProtective Effects of Ginsenoside Rd on PC12 Cells against Hydrogen Peroxide
Ye, R., Han, J., Kong, X., Zhao, L., Cao, R. Y., Rao, Z., & Zhao, G. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1923 · Cited by 77 · see citing works
Kashyap, P., Kalaivani, M., Niranjan, M., Trikha, S., & Kumar, S. (2019) · Steroids · doi:10.1016/j.steroids.2019.108529 · Cited by 77 · see citing works
A Perspective on Inflammation in Alzheimer's Disease
Rogers, J., & Shen, Y. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05571.x · Cited by 74 · cited 1× · see citing works
“The hypothesis is supported by epidemiological evidences, whereby it was observed that patients using anti-inflammatory agents for the management of chronic inflammatory diseases such as arthritis have a lower prevalence of AD [41].”
ResultHur, J., Lee, P., Moon, E., Kang, I., Kim, S., Oh, M. S., & Kim, S. Y. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.016 · Cited by 74 · cited 4× · see citing works
“Ginsenosides enhance the antioxidant potentials as well as upregulate the neuronal plasticity-associated proteins such as BDNF, p-CREB, PSD-95, phospho-calcium–calmodulin-dependent kinase II, phosphor-N-methyl-D-aspartate receptor 1, phosphor-PKA catalytic β subunit and PKCγ subunit in the hippocampus regions, which m…”
BackgroundInfluentialIntrinsic Regulation of Brain Inflammatory Responses
Galea, E., Heneka, M. T., Russo, C. D., & Feinstein, D. L. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025084415833 · Cited by 74 · cited 1× · see citing works
“Though the role of APOE gene polymorphisms, especially in APOEe4 carriers, is suggested to be involved, its exact mechanism remains unclear [51,52].”
BackgroundRole of microglia in plaque formation in senile dementia of the Alzheimer type
Rozemüller, A. J. M., Eikelenboom, P., & Stam, F. C. (1986) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899034 · Cited by 72 · cited 1× · see citing works
“During the early stages of AD, the role of oxidative stress is very crucial, since it is linked temporally to the development of NFTs and amyloid plaques [39].”
BackgroundProtective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro
Li, L., Liu, J., Yan, X., Qin, K., Shi, M., Tian, L., Zhu, Y., Kang, T., & Zhao, G. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.068 · Cited by 70 · cited 1× · see citing works
“immunoreactivity, as well as the expression of proenkephalin genes induced by methamphetamine in mouse striatum [130].”
BackgroundImpact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
Pinyopornpanish, K., Soontornpun, A., Wongpakaran, T., Wongpakaran, N., Tanprawate, S., Pinyopornpanish, K., Nadsasarn, A., & Pinyopornpanish, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18470-8 · Cited by 70 · cited 1× · see citing works
“It is observed that the rate of health service utilization among AD patients is very high and patients go through more falls and accidents as compared to age-matched controls [5,6].”
BackgroundZhang, Y., Fan, X., Li, X., Peng, L., Wang, G., Ke, K., & Jiang, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.037 · Cited by 67 · cited 1× · see citing works
“ginseng Ginsenoside Rg2 Stroke Anti-apoptosis [115,116]”
Tumour necrosis factor-α gene polymorphisms and Alzheimer's disease
Culpan, D., MacGowan, S. H., Ford, J. M., Nicoll, J. A. R., Griffin, W. S. T., Dewar, D., Cairns, N. J., Hughes, A., Kehoe, P. G., & Wilcock, G. K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00854-1 · Cited by 67 · cited 1× · see citing works
“For instance, the presence of polymorphic genes encoding IL-1 and TNFα were reported to cause excessive activation of microglia among AD patients [49,50].”
BackgroundPharmacological treatment of Alzheimer’s Disease
Bianchetti, A., Ranieri, P., Margiotta, A., & Trabucchi, M. (2006) · Aging Clinical and Experimental Research · doi:10.1007/bf03327433 · Cited by 66 · see citing works
Khalil, A. T., Ayaz, M., Ovais, M., Wadood, A., Ali, M., Shinwari, Z. K., & Mâaza, M. (2018) · Inorganic and Nano-Metal Chemistry · doi:10.1080/24701556.2019.1569686 · Cited by 66 · cited 1× · see citing works
“Only four antiAD agents are clinically approved, which include galanthamine (Reminyls®), donepezil (Aricept®), tacrine (Cognex®) and rivastigmine (Exelon®) [55,56].”
BackgroundSelf-citationZhou, Y., Yang, Z., Xu, L., Li, P., & Hu, Y. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.06.028 · Cited by 65 · cited 2× · see citing works
“For instance, the presence of polymorphic genes encoding IL-1 and TNFα were reported to cause excessive activation of microglia among AD patients [49,50].”
BackgroundHassan, S. S. U., Muhammad, I., Abbas, S. Q., Hassan, M., Majid, M., Jin, H., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111432 · Cited by 65 · see citing works
Self-citationBrain Atrophy in Normal Ageing and Alzheimer's Disease
Förstl, H., Zerfaß, R., Geiger-Kabisch, C., Sattel, H. C., Besthorn, C., & Hentschel, F. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.6.739 · Cited by 64 · cited 4× · see citing works
“In the entorhinal cortex, which links the hippocampus (involved in the formation of memory) with the cerebral cortex, the AD symptoms start initially [19].”
BackgroundInfluentialGu, B., Nakamichi, N., Zhang, W., Nakamura, Y., Kambe, Y., Fukumori, R., Takuma, K., Yamada, K., Takarada, T., Taniura, H., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22021 · Cited by 63 · see citing works
Dammarane-Type Saponins from Panax japonicus and Their Neurite Outgrowth Activity in SK-N-SH Cells
Zou, K., Zhu, S., Meselhy, M. R., Tohda, C., Cai, S., & Komatsu, K. (2002) · Journal of Natural Products · doi:10.1021/np0201117 · Cited by 61 · see citing works
Menzin, J., Lang, K., Friedman, M., Neumann, P. G., & Cummings, J. L. (1999) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199911000-00005 · Cited by 60 · see citing works
Xu, B., Liu, C., Gao, X., Zhang, W., Wang, S., & Cao, Y.-L. (2004) · Journal of Asian Natural Products Research · doi:10.1080/10286020410001690172 · Cited by 58 · cited 1× · see citing works
“MPTP is commonly used for the development of PD in experimental models, via suppressing the over-expression of cyclooxygenase-2, enhancing the tyrosine hydroxylase and suppressing mitochondria-mediated apoptosis [100].”
MethodLocalization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells
SUZUKI, D. A., Nomura, S., Morii, E., Fukuda, Y., & Kosaka, J. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981001)54:1 · Cited by 57 · see citing works
Yabe, T., Tuchida, H., Kiyohara, H., Takeda, T., & Yamada, H. (2003) · Phytomedicine · doi:10.1078/094471103321659799 · Cited by 56 · see citing works
Lee, E.-Y., Kim, S., Chung, K. C., Choo, M., Kim, D., Nam, G., & Rhim, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.038 · Cited by 55 · see citing works
McClure, R., Ong, H., Janve, V., Barton, S., Zhu, M., Li, B., Dawes, M., Jerome, W. G., Anderson, A., Massion, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160289 · Cited by 54 · see citing works
Saleem, U., Akhtar, R., Anwar, F., Shah, M. A., Chaudary, Z., Ayaz, M., & Ahmad, B. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00683-x · Cited by 53 · cited 1× · see citing works
“As this is a permanent reaction, when the reactive species are attached to certain biological molecules, this alters them both structurally and functionally [35,36] and causes genetic mutations.”
BackgroundSelf-citationLee, M.-R., Yun, B.-S., In, O.-H., & Sung, C. K. (2011) · Journal of Ginseng Research · doi:10.5142/jgr.2011.35.4.421 · Cited by 50 · cited 2× · see citing works
“23 Platycodon grandiflorum Platycodin D Stroke NF-κB, COX-2 [121]”
BackgroundHe, L., Mu, L., Jean, J. A., Zhang, L., Wu, H., Zhou, T. J., & Bu, H. (2022) · The British Journal of Social Work · doi:10.1093/bjsw/bcac077 · Cited by 49 · see citing works
Qian, Y., Han, H., Hu, X., & Shi, L.-L. (2009) · Neurological Research · doi:10.1179/174313209x385572 · Cited by 47 · see citing works
Neuroprotective Studies on Polygonum hydropiper L. Essential Oils Using Transgenic Animal Models
Tong, X., Li, X., Ayaz, M., Ullah, F., Sadiq, A., Ovais, M., Shahid, M. M., Khayrullin, M., & Ali, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.580069 · Cited by 44 · cited 1× · see citing works
“Excessive amount of free radicals readily attack various biological molecules, including neurons, and also cause mutations [25].”
BackgroundSelf-citationChoi, J. H., Yoo, K., Park, O. K., Lee, C. H., Won, M., Hwang, I. K., Ryu, S. Y., Kim, Y. S., Yi, J., Bae, Y., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.005 · Cited by 43 · see citing works
Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy: A Comprehensive Review
Rong, X., Jiang, L., Qu, M., Hassan, S. S. U., & Liu, Z. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201023144836 · Cited by 43 · cited 2× · see citing works
“As this longer β1–42 rapidly forms the amyloid fibrils as compared to Aβ1–40, shifting of the cleavage site may cause the deposition of amyloid without enhancing the overall quantity of produced Aβ [29].”
BackgroundSelf-citationYu, X., Wang, L., Ma, L., You, R., Cui, R., Ji, D., Wu, Y., Zhang, C., Yang, Z., & Ji, H. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.02.014 · Cited by 42 · cited 4× · see citing works
“In the cultured cortical neurons, ginsenoside Rb1 attenuates Aβ-induced toxicity in a dose-dependent manner [98].”
BackgroundInfluentialProgress with Treatments for Alzheimer’s Disease
Levey, A. I. (2021) · New England Journal of Medicine · doi:10.1056/nejme2103722 · Cited by 41 · cited 1× · see citing works
“Alzheimer’s disease (AD) is a highly prevalent neurological disorder of old age and associated with behavioral and cognitive complications [1,2].”
BackgroundHayes, A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.030866 · Cited by 38 · cited 1× · see citing works
“The inflammatory hypothesis in AD also suggests that polymorphisms in the genes regulating the inflammatory process cause sporadic AD [48].”
BackgroundOyeleke, M. B., & Owoyele, B. V. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.114997 · Cited by 38 · cited 5× · see citing works
“8 Astragalus membranaceus Astragaloside IV PD, Stroke Antioxidant, tumor interleukin-1β (IL-1β), necrosis factor α (TNFα), Nuclear factor kappa B (NF-κB), Ca2+ influx, regeneration of the neural network [74]”
BackgroundInfluentialHostettmann, K., & Marston, A. (2005) · Elsevier eBooks · doi:10.1016/b0-12-369397-7/00548-3 · Cited by 37 · see citing works
Photoclick Reaction Constructs Glutathione-Responsive Theranostic System for Anti-Tuberculosis
Zheng, J., Long, X., Chen, H., Ji, Z., Shu, B., Yue, R., Liao, Y., Ma, S., Qiao, K., Liu, Y., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.845179 · Cited by 34 · cited 1× · see citing works
“The total saponin content of Dipsacus asper has also been reported to offer protection against Aβ-induced neuronal toxicity [97].”
BackgroundNatural Products for Chronic Diseases: A Ray of Hope
Hassan, S. S. U., Abdel‐Daim, M. M., Behl, T., & BUNGAU, S. G. (2022) · Molecules · doi:10.3390/molecules27175573 · Cited by 32 · cited 1× · see citing works
“Initially, the presence of immune system cells and antigens around the Aβ aggregates and tau proteins in AD patients brain signals the involvement of inflammatory process in the pathogenesis of AD [40].”
BackgroundSelf-citationKalopanaxsaponins A and B Isolated from Kalopanax pictus Ameliorate Memory Deficits in Mice
Joh, E., Lee, I., & Kim, D. (2011) · Phytotherapy Research · doi:10.1002/ptr.3596 · Cited by 30 · cited 1× · see citing works
“5 Polygala tenuifolia Onjisaponin F AD Nerve growth factor (NGF), Choline Acetyltransferase (ChAT) [108]”
BackgroundProtective effects of xanthoceraside on learning and memory impairment induced by Aβ25–35in mice
Chi, T., Wang, L.-H., Qu, C., Yang, B.-Z., Ji, X., Wáng, Y., Okuyama, T., Okada, Y., & Zou, L. (2009) · Journal of Asian Natural Products Research · doi:10.1080/10286020903337832 · Cited by 30 · see citing works
Gypenoside TN-2 ameliorates scopolamine-induced learning deficit in mice
Hong, S.-W., Yang, J.-H., Joh, E., Kim, H. J., & Kim, D. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.02.002 · Cited by 28 · cited 1× · see citing works
“Madecassosides have been reported to exhibit neuroprotective activity in MPTP-induced Parkinsonism models and could retrieve the DA (dopamine) depletion and enhance the Bcl-2/Bax ratio and BDNF protein expression [103].”
BackgroundSteroidal glycoalkaloid content of potato, tomato and their somatic hybrids
Roddick, J. G., & Melchers, G. (1985) · Theoretical and Applied Genetics · doi:10.1007/bf00252292 · Cited by 28 · cited 1× · see citing works
“The tubers of Dioscorea villosa (wild yam) have saponin dioscin in abundance, which upon hydrolysis, gives diosgenin, a steroidal aglycone, which is used as a precursor for steroid synthesis, including pregnenolone, progesterone and cortisone commercially [87,88].”
BackgroundKaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., Badavath, V. N., Hassan, S. S. U., Hasan, M. M., Bhatia, S., Al-Harassi, A., et al. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00820-6 · Cited by 28 · cited 1× · see citing works
“The positions of these mutations proposed that it may contribute to the development of AD by changing the processing of βAPP in such a manner which is amyloidogenic [29,30].”
BackgroundSelf-citationShin, E., Koh, Y. H., Kim, A., Nah, S.-Y., JEONG, J., CHAE, J., KIM, S., YEN, T., Yoon, H., & KIM, W. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.038 · Cited by 26 · see citing works
Cognition-Enhancing and Neuroprotective Effects of Hederacolchiside-E from Pulsatilla koreana
Han, C.-K., Choi, W. W., & Oh, K.-B. (2007) · Planta Medica · doi:10.1055/s-2007-981530 · Cited by 25 · cited 1× · see citing works
“These results shows that ginseng, as well as the purified ginsenosides, might show similar useful effects [95].”
BackgroundKhan, M. I., Khan, M. Z., Shin, J. H., Shin, T. S., Lee, Y. B., Kim, M. Y., & Kim, J. D. (2022) · Molecules · doi:10.3390/molecules27072079 · Cited by 22 · cited 4× · see citing works
“The saponin inhibited amyloid beta (Aβ42) fibrillization up to 68% at a 40 μM concentration [76].”
BackgroundMethodInfluentialMalik, N., Amber, S., & Zahid, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.943163 · Cited by 22 · cited 2× · see citing works
“The thread of a neuropil consists of small-sized curly and dystrophic neurites that are scattered in neuropils and holding some abnormal filaments [31,32].”
BackgroundShin, E., Nabeshima, T., Suh, H., Jhoo, W., Oh, K., Lim, Y. K., Kim, D. S., Choi, K. H., & Kim, H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.018 · Cited by 21 · see citing works
Conrado, D. J., Duvvuri, S., Geerts, H., Burton, J., Biesdorf, C., Ahamadi, M., Macha, S., Hather, G., Francisco Morales, J., Podichetty, J., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1782 · Cited by 21 · see citing works
Phytochemicals-based Therapeutics against Alzheimer's Disease: An Update
Ayaz, M., Nawaz, A., Naz, F., Ullah, F., Sadiq, A., & Islam, Z. U. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220815104305 · Cited by 21 · cited 3× · see citing works
“Currently available AD agents are associated with severe side effects and have limited efficacy [5].”
BackgroundSelf-citationQian, Y., Liu, Y. U., Hu, H., Ren, H.-M., Chen, X., & Xu, J. (2002) · Anatomical Science International · doi:10.1046/j.0022-7722.2002.00029.x · Cited by 20 · cited 1× · see citing works
“Hederacolchiside-E, which is an oleanolic glycoside when given orally at 30 and 60 mg kg−1 doses, shows an increase in the step-through latency time as efficiently as tacrine given at a 30 mg kg−1 oral dose using the passive avoidance paradigm [96].”
MethodFaheem, M., Khan, A., Shah, F. A., & Li, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1019033 · Cited by 20 · see citing works
Bioactive Complex Triterpenoid Saponins from the Leguminosae Family
Parente, J. P., & da Silva, B. P. (2009) · Natural Product Communications · doi:10.1177/1934578x0900400131 · Cited by 11 · cited 1× · see citing works
“Various plant families synthesize and store saponins [78,80,81].”
BackgroundEditorial: Current Trends in Medicinal Plant Research and Neurodegenerative Disorders
Ayaz, M., Ali, T., Sadiq, A., Ullah, F., & Naseer, M. I. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922373 · Cited by 10 · see citing works
Self-citationYadav, M., Pandey, P., & Sharma, P. (2022) · European Journal of Biological Research · doi:10.5281/zenodo.6323798 · Cited by 3 · see citing works
Current Trends in Medicinal Plant Research and Neurodegenerative Disorders
(2022) · Frontiers research topics · doi:10.3389/978-2-88976-633-8 · Cited by 2 · see citing works
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Flagged first, then by citations
4 of the 132 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [85]Hostettmann K. Marston A. Saponins Cambridge University Press Cambridge, UK 2005
- [91]Hostettmann K. Marston A. Chemistry and Pharmacology of Natural Products Cambridge University Press Cambridge, UK 1995 Volume 548
Cited by
Sorted by citations
Baran, M. F., Keskin, C., Baran, A., Hatipoğlu, A., Yıldıztekin, M., Küçükaydın, S., Kurt, K., Hoşgören, H., Sarker, M. M. R., Sufianov, A. A., et al. (2023) · Molecules · doi:10.3390/molecules28052310 · Cited by 153 · see citing works
“Numerous research has been carried out demonstrating the potential of plant-based synthetic metallic nanoparticles as anticholinesterase drugs [17].”
BackgroundAntiaging effects of dietary supplements and natural products
Gao, L., Liu, X., Luo, X., Lou, X., Li, P., Li, X., & Liu, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192714 · Cited by 60 · see citing works
“Rb1, Rb2, Rc, and Rd have more glycosyl groups on C-3 and C-20 than rare ginsenosides, including F2, Rg3, Rh2, and C-K (Hou et al., 2021; Abduljawad et al., 2022).”
BackgroundEffect of nutrition in Alzheimer’s disease: A systematic review
Lou, I. X., Ali, K., & Chen, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1147177 · Cited by 58 · see citing works
“Following a healthy dietary pattern, a high intake of plant-based foods, probiotics, nuts, and omega-3 polyunsaturated fatty acids and a low intake of saturated fats, animal-based proteins, and refined sugars can decrease the risk of neurocognitive impairment (Pistollato et al., 2018; Abduljawad et al., 2022).”
BackgroundRecent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56 · see citing works
Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances
Khan, S. U., Khan, M. I., Khan, M. U., Khan, N. M., BUNGAU, S. G., & Hassan, S. S. U. (2022) · Bioengineering · doi:10.3390/bioengineering10010051 · Cited by 33 · see citing works
Self-citationAilioaie, L. M., Ailioaie, C., & Litscher, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030916 · Cited by 37 · see citing works
Zulfugarova, P., Zivari‐Ghader, T., Maharramova, S., Ahmadian, E., Eftekhari, A., Khalilov, R. I., Türksoy, V. A., Rosic, G. L., & Selaković, D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1148258 · Cited by 30 · see citing works
Weaver, D. F. (2023) · Brain Sciences · doi:10.3390/brainsci14010041 · Cited by 31 · see citing works
“The Mediterranean diet, the related MIND diet (which incorporates constituents designed to lower blood pressure) and other healthful dietary regimens are associated with cognitive benefits in studies and a decreased probability of AD [53–56].”
Therapeutic Candidates for Alzheimer’s Disease: Saponins
Zhang, R., Zeng, M., Zhang, X., Zheng, Y., Lv, N., Wang, L., Gan, J., Li, Y., Jiang, X., & Yang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310505 · Cited by 28 · see citing works
“Sapo ins possess multiple bio ctivities, such as re uction of amyloid beta (Aβ) deposition [22], inhibition of tau pr tein pho phoryl tion [23], antioxidation [24], antiapoptosis [25], and anti-i flammati n [26].”
BackgroundMahnashi, M. H., Ashraf, M., Alhasaniah, A. H., Ullah, H., Zeb, A., Ghufran, M., Fahad, S., Ayaz, M., & Daglia, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115144 · Cited by 25 · see citing works
Self-citationThandivel, S., Poovarasan, R., Tamizharasan, G., Abisek, A., Khute, S., Kareti, S. R., & Subash, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27880 · Cited by 24 · see citing works
“AD is a neurodegenerative disorder affecting memory, thinking, and behaviour, causing language difficulties, disorientation, mood changes, and personality changes in individuals [1].”
BackgroundAlghamdi, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18071041 · Cited by 22 · see citing works
“AD is a degenerative disease of the nervous system among the elderly population, which drastically affects patients’ thinking, memory, and behavior [44].”
Manju, & Bharadvaja, N. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00783-2 · Cited by 17 · see citing works
“Indian ginseng or ashwa-gandha India, the middle east, and some parts of Africa Rh1, Rg3 Used in Ayurvedic medicine to improve vitality, reduce stress and boost the immune system [20] the brain [23].”
Mahnashi, M. H., Ayaz, M., Alqahtani, Y. S., Alyami, B. A., Shahid, M. M., Alqahtani, O. S., Kabrah, S. M., Zeb, A., Ullah, F., & Sadiq, A. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116786 · Cited by 17 · see citing works
Self-citationLin, Z., & Sun, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107790 · Cited by 14 · see citing works
Kysel, P., Haluzíková, D., Pleyerová, I., Řezníčková, K., Laňková, I., Lacinová, Z., Havrlantová, T., Mráz, M., Kasperová, B. J., Kovarova, V., et al. (2023) · Nutrients · doi:10.3390/nu15071720 · Cited by 14 · see citing works
Lou, I. X., Chen, J., Ali, K., Shaikh, A. L., & Chen, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190604 · Cited by 13 · see citing works
“Various nutrients and nutraceuticals have been linked to improvements in cognition and other psychological aspects related to AD (Guzman-Martinez et al., 2021; Abduljawad et al., 2022; Mahnashi et al., 2022; Xu Lou et al., 2023) Some examples include Gingko Biloba (Liao et al.”
BackgroundLaouini, S. E., Bouafia, A., Azzi, M., Laib, I., Fellah, M., Abdullah, M. M. S., Al‐Lohedan, H. A., & Abdullah, J. A. A. (2025) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35661 · Cited by 12 · see citing works
Rehman, Y. U., Iqbal, A., Ali, G., Alotaibi, G., Ahmed, A., & Ayaz, M. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04309-w · Cited by 11 · see citing works
“Oxidative stress is a warning that a cell’s capacity for antioxidant defence is being overwhelmed by the destructive generation of reactive oxygen and nitrogen species (RONS) [10].”
BackgroundSelf-citationThe roles of natural triterpenoid saponins against Alzheimer's disease
Zhou, J., Li, H., Zhou, Y. J., Li, X., Yang, Z., Tohda, C., Komatsu, K., Piao, X., & Ge, Y. (2023) · Phytotherapy Research · doi:10.1002/ptr.7967 · Cited by 9 · see citing works
“Natural triterpenoid saponins (TS), found in medicinal plants such as ginseng, Panax notoginseng , wild jujube, Siberian ginseng, and American ginseng (Abduljawad et al., 2022), have been demonstrated significant neuroprotective effects in attenuating nervous system disorders including AD.”
BackgroundMahnashi, M. H., Ayaz, M., Ghufran, M., Almazni, I. A., Alqahtani, O. S., Alyami, B. A., Alqahtani, Y. S., Khan, H. A., Sadiq, A., & Waqas, M. S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2265494 · Cited by 7 · see citing works
“Beta secretase/BACE1, a membrane-bound aspartyl-prote-ase enzyme, is implicated in the catalytic processing of the amyloid precursor protein (APP) to form amyloidogenic plaques known as A b (Abduljawad et al., 2022; Moussa-Pacha et al., 2020).”
Self-citationZhao, H., Hu, X., Guan, S., Cai, J., Li, X., Fang, J., Lin, B., Zhu, W., Tian, J., Jin, J., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1361643 · Cited by 7 · see citing works
Luo, L., Pan, Y., Chen, F., & Zhang, Z. (2024) · Medicine · doi:10.1097/md.0000000000040726 · Cited by 6 · see citing works
Shah, Z., Iqbal, A., Badshah, S. L., Mir, M. A., Sohni, S., Ullah, H., Shah, S. A., Bashir, N., Ayaz, M., & Daglia, M. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10230-5 · Cited by 6 · see citing works
“Scientific exploration of natural resources including marine organisms, herbal products, and their derived secondary metabolites represent valuable alternative sources for the discovery of new drugs against human diseases (Abduljawad et al. 2022).”
Self-citationYoussef, B., Ibrahim, E. A., Moselhy, S. S., ElShebiney, S. A., & ELabd, W. K. (2025) · Discover Nano · doi:10.1186/s11671-025-04356-x · Cited by 7 · see citing works
Naz, S., Imran, I., Farooq, M. A., Shah, S. A. H., Ajmal, I., Zahra, Z., Aslam, A., Sarwar, M. I., Shah, J., & Aleem, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1077570 · Cited by 6 · see citing works
Antineuroinflammatory Potential of Uvaol Transformation Products by Three Fungal Species
Wang, J., We, L., Lu, J., Zhu, M., Wu, Y., Pan, W., Fan, B., Song, Y., Wang, W., & Chen, G. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c09088 · Cited by 6 · see citing works
Saponins: A class of bioactive natural products with wide applications in human health
da Silva, R. M. G., Kacew, S., & Granero, F. O. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15756-1.00013-6 · Cited by 5 · see citing works
Bosco, R. B. D., Christyraj, J. R. S. S., & Yesudhason, B. V. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307019 · Cited by 5 · see citing works
Rahman, M. O., Ahmed, S. S., Alqahtani, A. S., Rehman, M. T., Sultana, N., Bouhrim, M., Ali, M. A., & Lee, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-20527-3 · Cited by 4 · see citing works
Eranhottu, S., Cherian, T., Mohanraju, R., Devi, N. S., Sanal, J., Varghese, L. S., Ambili, P., Thomas, M., Fahmeeda Parveen, P. S., & Peijnenburg, W. J. G. M. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100600 · Cited by 4 · see citing works
“16 16 – 18 Noble-metal nanomaterials have remarkable chemical and physical qualities that enable unique interactions with the environment.”
Karabulut, G., Günal‐Köroğlu, D., Yılmaz, H., Erskine, E., & Çapanoğlu, E. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102929 · Cited by 4 · see citing works
Srivastava, S., Deep, S., & Khare, S. K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144315 · Cited by 4 · see citing works
Formulating Treatment to Cure Alzheimer’s Dementia: Approach #2
Fessel, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063524 · Cited by 5 · see citing works
“…by saponins, which provide neuroprotective mechanisms, including those of free radical scavenging, the modulation of neuroprotective signaling pathways, the activation of neurotrophic factors, the modulation of neurotransmitters, the inhibition of BACE1 enzyme, and tau hyperphosphorylation [63].”
BackgroundHan, Q., Wang, J., Long, L., Wang, N., & Xiao, J. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115364 · Cited by 3 · see citing works
Dengzhan Shengmai capsule ameliorates cognitive impairment via inhibiting ER stress in APP/PS1 mice
Ma, H., Zheng, J., Qiu, Y.-H., Su, S., Lu, F.-M., Wu, G., Zhang, S., & Cai, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119016 · Cited by 2 · see citing works
Nanoparticle-Based Biomarkers for Neurological Disorders
Kiran, N. S., Yashaswini, C., Chatterjee, A., Ali, N., & Prajapati, B. G. (2025) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-80185-3_6 · Cited by 3 · see citing works
Basha, E. K., & Dhamodaran, V. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00291-8 · Cited by 2 · see citing works
“This lowers inflammation and speeds up healing in a number of inflammatory conditions [22].”
Nutrition and Neuroinflammation
Na’Allah, A., Asuku, A. O., AbdulRazaq, A., Ambali, O. A., Oyeleke, M. B., & Odetayo, A. F. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1983-5_3 · Cited by 2 · see citing works
Liu, X., Zhou, Y., Meng, R., Han, J., Chen, M., Bo, X., Li, S., Song, D., & Zhang, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1682948 · Cited by 2 · see citing works
“However, these agents exhibit suboptimal efficacy and are associated with significant adverse effects, such as hepatotoxicity (31, 32).”
Sheng, R., Zhao, M., Pu, K., Zhou, Y., Zeng, L., Chen, Y., Wang, P., Liu, X., & Xu, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70010 · Cited by 2 · see citing works
“Studies have shown that saponins are significant neuroprotective agents, with ginsenosides, astraga-loside, sarsasapogenin, and timosaponin being among the most studied (Abduljawad et al. 2022; Yang et al. 2023; Yao, Zhang, and Wang 2023).”
Salem, M. A., Abdel-Sattar, E. A., Mandour, A. A., & El‐Shiekh, R. A. (2025) · RSC Advances · doi:10.1039/d5ra00021a · Cited by 1 · see citing works
Alzheimer’s Disease: A Study on Natural and Herbal Treatment
Salve, P. S., Pohankar, A. A., George, S., & Gadge, J. R. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00132 · Cited by 1 · see citing works
León, F., Zakid, A. A., Gupta, S., Mukhopadhyay, S., Tarawneh, A. H., Obeng, S., Cutler, S. J., & McCurdy, C. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00490-5 · Cited by 1 · see citing works
Oladoja, F. A., Awodele, O., Oreagba, I. A., Irokosu, E. S., Oyinloye, E. O., Murtala, A. A., Ganiyu-Abideen, N. A., & Pender, G. C. (2025) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqaf010 · Cited by 1 · see citing works
Ahmed, A., Khan, H. R., Shen, Y., Xu, S., Zhao, Y., Lv, J., Zhu, X., Fu, X., & Li, P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251404020 · Cited by 1 · see citing works
Self-citationSusilo, S., Aini, F. N., & Permanasari, E. D. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00105 · Cited by 1 · see citing works
Saponins Effect on Human Insulin Amyloid Aggregation
Mari, E., Vilasi, S., Moretti, P., Mangione, M. R., Giorgini, G., Galeazzi, R., & Ortore, M. G. (2024) · Biomolecules · doi:10.3390/biom15010040 · Cited by 1 · see citing works
“Also, even more recently, a few papers suggested the promising role of saponins against neurodegenerative diseases [18,19].”
Neurotransmitter Modulation and Cognitive Enhancement
Kumar, D., Singh, R. K., & Mishra, A. K. (2025) · Springer eBooks · doi:10.1007/978-981-95-0125-0_4 · Cited by 1 · see citing works
Biancardi, I. M., Carneiro, I. R., SILVA, M. L. R. D., Quincór, R. R. D. S., & Sardinha, R. M. (2023) · Congresso Brasileiro de Estudos Patológicos On-line · doi:10.51161/ii-conbesp/14165
Akinyemi, P. A., Adebesin, O. A., Arotiba, O. M., Adewole, A. R., & Okpuzor, J. E. (2023) · Journal of applied science and environmental management · doi:10.4314/jasem.v27i11.36
“The study by Abduljawad et al. (2022) concluded that Saponins have considerable efficacy against various pathological targets of neurological disorders.”
BackgroundLuo, L., Pan, Y., Chen, F., & Zhang, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4225413/v1
Novel Galantamine-ferulicacid hybrids: A Multi-target approach to Alzheimer’s disease
Singh, S., & Kakadiya, J. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00316
Nutritional profile, medicinal properties and growing businesses of Moringa oleifera: A review
Patel, D., Patel, Y. K., Vithalkar, A., & Kaiwartya, K. (2025) · International Journal of Agriculture and Food Science · doi:10.33545/2664844x.2025.v7.i7d.519
Burigo, F. E. T., & Pincerati, M. R. (2025) · Aracê. · doi:10.56238/arev7n10-295
Rehman, Y. U., Iqbal, A., Ali, G., Alotaibi, G., Ahmed, A., & Ayaz, M. (2024) · Figshare · doi:10.6084/m9.figshare.24934223
Self-citationUllah, F., Hayat, A., Mir, M. A., Khan, M. A., Bashir, N., Mosa, O. F., Sadiq, A. M. M., & Ayaz, M. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00720-z
“…screening of plant-derived compounds which have the capacity to inhibit enzymes, scavenge free radicals, and affect plant growth is not only helping in the identification of new drug candidates but is also supporting efforts to find eco-friendly alternatives to synthetic agrochemicals [12–14].”
Self-citationBadal, R., Kaur, B., Singh, H., Sharma, P., Yadav, P., Mahapatra, A., Ghildiyal, S., Patel, A. K., Kumar, L., Sharma, B., et al. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111742
Luo, J., Luo, J., Huang, Y., Lei, Q., Wu, Y., Han, B., & Xu, B. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17741
Chakraborty, A., & Guha, S. (2026) · Recent Progress in Nutrition · doi:10.21926/rpn.2602008
Bastos, I. M., Moreira, D. R., Rebelo, S., & Silva, V. L. M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118161
Natural products in neurodegenerative diseases: role of serine/threonine kinases
Ahmed, L. A., Ahmed, M. K., Sayed, N. S. E., & Farag, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00023-1
El‐Shiekh, R. A., Mandour, A. A., Abdel-Sattar, E. A., & Ali, N. B. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2727544
- Authors
- Abduljawad, A. A., Elawad, M. A., Elkhalifa, M. E. M., Ahmed, A., Hamdoon, A. A. E., Salim, L. H. M., Ashraf, M., Ayaz, M., Hassan, S. S. U., & Bungau, S.
- Affiliations
- Umm al-Qura University (SA)
- University of Khartoum (SD)
- University of Malakand (PK)
- Shanghai Jiao Tong University (CN)
- University of Oradea (RO)
- Corresponding author
- Abduljawad, Asaad A.
- Ayaz, Muhammad
- Hassan, Syed Shams ul
- Bungau, Simona
- ORCID
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-10-11
- Volume
- 27
- Issue
- 20
- Pages
- 6804
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC9608803
- OpenAlex
- W4304632685
- Cited by
- 63
- References
- 132
- Citations by year
- 2026: 7 · 2025: 24 · 2024: 14 · 2023: 16 · 2022: 2
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Natural product bioactivities and synthesis
- Keywords
- saponins, Alzheimer's disease, neurodegenerative diseases, neuroprotection, triterpenoid saponins, steroid glycosides, free radical scavenging, neurotrophic factors, neurotransmitters, BACE1 inhibition, tau hyperphosphorylation, Huntington's disease, Parkinson's disease, dietary phytochemicals
- MeSH terms
- Alzheimer Disease, Free Radicals, Glycosides, Humans, Nerve Growth Factors, Public Health, Saponins, Steroids, Triterpenes, Aspartic Acid Endopeptidases, Neurotransmitter Agents, Neurodegenerative Diseases, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review